Skip to content
Recall Observatory FDA recall evidence

Drug product

Cetrorelix Acetate for Injection, 0.25 mg, , One carton contains one packaged tray which contains: 1 vial with lyophilized powder for reconstitution, 1 pre-filled syringe with diluent, 1 20-gauge needle, 1 27-gauge needle, Sterile - For subcutaneous use only, Rx Only, Manufactured by: GP Pharm S.A. Barcelona, Spain (ESP) -08777, Distributed by: Akorn Operating Company, LLC., Gurnee, IL 60031. ALL NDCs

D-0791-2023

April 26, 2023

Class II

Product summary

Firm
Akorn, Inc.
Event
Event 91788
Status
Ongoing
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0791-2023

Official wording

Reason: CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Code information: All Lots

Distribution pattern: Nationwide in the USA and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations